A2Sign: Agnostic Algorithms for Signatures-a universal method for identifying molecular signatures from
Galina Boldina1, Paul Fogel2,3,4, Corinne Rocher1
1Sanofi, R&D Translational Sciences France, Bioinformatics, Sanofi, F-91385 Chilly-Mazarin Cedex, France.
Bioinformatics (Oxford, England)
|November 17, 2021
Summary
A new data-driven method, A2Sign, uses non-negative tensor factorization to identify cell-type molecular signatures from bulk transcriptomics. This approach enables accurate cell-type deconvolution without prior biological knowledge, even for novel tissues.
Area of Science:
- Computational biology
- Genomics
- Bioinformatics
Background:
- Molecular signatures are crucial for cell-type proportion inference from bulk transcriptomics.
- Current methods require prior biological knowledge, limiting their use with less-studied tissues.
- A data-driven approach is needed to discover cell types and generate signatures from complex biological samples.
Purpose of the Study:
- To introduce A2Sign (Agnostic Algorithms for Signatures), a novel computational framework for identifying cell-type-specific molecular signatures.
- To enable cell-type deconvolution from bulk transcriptome data in arbitrary tissues without prior biological knowledge.
- To account for inter-individual variability and reduce collinearity in molecular signatures.
Main Methods:
- Utilized non-negative tensor factorization (NTF) as the core strategy within the A2Sign framework.
- Developed a global approach applicable to diverse tissues and transcriptomic data types (microarray, RNA-seq).
- Implemented the analysis using annotated Python notebooks and the NMTF package.
Main Results:
- Successfully identified cell-type-specific molecular signatures using a data-driven, agnostic approach.
- Demonstrated the ability to reduce collinearities and incorporate inter-individual variability.
- Generated two novel molecular signatures for deconvoluting up to 16 immune cell types.
Conclusions:
- A2Sign provides a powerful, flexible framework for molecular signature discovery and cell-type deconvolution.
- The method overcomes limitations of knowledge-based approaches, expanding transcriptomic analysis to new biological contexts.
- The developed signatures facilitate accurate immune cell profiling from bulk tissue data.


